Breast Cancer ER PR HER2 Ki67 Test
Introduction to the Test
The Breast Cancer ER PR HER2 Ki67 test is a crucial diagnostic tool used to evaluate breast cancer. This test analyzes specific markers in tumor tissue, which can help oncologists determine the most effective treatment strategies for patients. Understanding these markers is essential for personalized medicine in oncology.
What the Test Measures
This test measures the following components:
- Estrogen Receptor (ER)
- Progesterone Receptor (PR)
- HER2/neu
- Ki-67 (a proliferation marker)
These components provide valuable information about the tumor’s biology and its potential response to hormone therapy.
Who Should Consider This Test?
Patients who should consider this test include:
- Women diagnosed with breast cancer
- Those with a family history of breast cancer
- Individuals exhibiting symptoms such as lumps or changes in breast appearance
- Patients with risk factors like age, genetics, or previous breast conditions
Benefits of Taking the Test
The benefits of the Breast Cancer ER PR HER2 Ki67 test include:
- Guiding treatment decisions based on tumor characteristics
- Identifying patients who may benefit from targeted therapies
- Helping predict the prognosis and aggressiveness of the cancer
- Providing peace of mind through informed medical choices
Understanding Your Results
Results from the Breast Cancer ER PR HER2 Ki67 test will indicate the presence of hormone receptors and the proliferation rate of the cancer cells. A qualified pathologist will review the results to ensure accuracy. Your oncologist will interpret these results to help plan your treatment.
Test Details
| Test Name | Breast Cancer ER PR HER2 Ki67 |
|---|---|
| Discount Price | 28,000 KSh |
| Regular Price | 40,000 KSh |
Sample Submission and Instructions
To conduct the test, please submit tumor tissue in 10% Formal-saline or a Formalin fixed paraffin embedded block. The sample should be shipped at room temperature. Additionally, provide a copy of the Histopathology report, clinical history, and indicate the site of biopsy.
Turnaround Time
The results for the Breast Cancer ER PR HER2 Ki67 test are typically available within 10 days.
Book Your Test Today!
We have branches across Kenya, making it convenient for you to access our services. For more information or to schedule your test, please call or WhatsApp us at +254711564616.
